Table 1. Hospitals Meeting Threshold for National Accreditation Program for Rectal Cancer Adherence by Process Standard.
| Process Standards per NAPRC Threshold | Hospitals Meeting Standard by Hospital Volume, No. (% of All Hospitals) | Mean Adherence to Specific Process Standard Across All Hospitals, % | |
|---|---|---|---|
| <20 Cases per Year (n = 1211) | ≥20 Cases per Year (n = 104) | ||
| Complete pathologic test report (95%) | 153 (12.6) | 4 (3.8) | 76.0 |
| Clinical staging performed (95%) | 1007 (83.1) | 92 (88.5) | 97.6 |
| CEA obtained (75%) | 486 (40.1) | 34 (32.7) | 66.4 |
| Treatment within 60 d of diagnosis (80%) | 998 (82.4) | 87 (83.7) | 86.9 |
| Neoadjuvant/adjuvant chemoradiotherapy for stages II and III rectal cancer (85%) | 499 (41.2) | 30 (28.8) | 78.7 |
| Aggregate No. of process standards met | |||
| 0/5 | 31 (2.6) | 2 (1.9) | NA |
| 1/5 | 143 (11.8) | 16 (15.4) | NA |
| 2/5 | 393 (32.5) | 41 (39.4) | NA |
| 3/5 | 399 (32.9) | 32 (30.8) | NA |
| 4/5 | 208 (17.2) | 12 (11.5) | NA |
| 5/5 | 37 (3.1) | 1 (1.0) | NA |
Abbreviations: CEA, carcinoembryonic; NA, not applicable; NAPRC, National Accreditation Program for Rectal Cancer.